About Hatchtech

Single application head lice product capable of killing both eggs and lice.

Investors

Hatchtech is a venture backed private company backed by some of the largest and most influential life sciences investors in Australia:

 

Latest News

Aug 03, 2020 Xeglyze FDA Approval

Sep 14, 2015 Commercialisation Deal and NDA Filed

Sep 02, 2014 Hatchtech Announces Successful Phase 3 Results

Oct 31, 2013 Hatchtech Completes $12.6m Capital Raise, Secures Funds for Phase III and NDA Submission